Sorafenib Inhibits Tumor Growth and Improves Survival in a Transgenic Mouse Model of Pancreatic Islet Cell Tumors

Figure 1

Study design for the assessment of Sorafenib in early and late treatment groups to analyze stage-dependent therapeutic effects.